Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Filter

Your Filters

Reset filters

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma.

Authors : Egerer, Mara¹ (AUTHOR) ; Schuch, Kathrin² (AUTHOR) ; Schöler, David² (AUTHOR)

Source: Cancers. Nov2024, Vol. 16 Issue 21, p3651. 13p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Intraperitoneal Chemotherapy without Bevacizumab versus Intravenous Chemotherapy with Bevacizumab as the Frontline Adjuvant Therapy in Advanced Ovarian Cancer.

Authors : Ting, Wan-Hua^1,2 (AUTHOR) ; Chen, Hui-Hua^1,3 (AUTHOR); Wei, Ming-Chow¹ (AUTHOR)

Source: Cancers. Oct2024, Vol. 16 Issue 19, p3382. 11p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Basic Fibroblast Growth Factor Accumulation in Culture Medium Masks the Direct Antitumor Effect of Anti-VEGF Agent Bevacizumab.

Authors : Wang, Zhiyong¹ (AUTHOR); Wang, Ziyi¹ (AUTHOR); Deng, Liyan¹ (AUTHOR)

Source: Doklady Biochemistry & Biophysics. Aug2024, Vol. 517 Issue 1, p285-290. 6p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Progression pattern and post‐progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.

Authors : Kobayashi, Satoshi¹ (AUTHOR) ; Fukushima, Taito¹ (AUTHOR); Ueno, Makoto¹ (AUTHOR)

Source: Liver International. Jun2024, Vol. 44 Issue 6, p1343-1350. 8p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab.

Authors : Sang, Yun Beom¹ (AUTHOR) ; Lee, Chaeryoung² (AUTHOR) ; Kim, Seul-Gi¹ (AUTHOR)

Source: Journal of Clinical Medicine. Mar2024, Vol. 13 Issue 5, p1335. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma.

Authors : Nakabori, Tasuku¹ (AUTHOR) ; Higashi, Sena¹ (AUTHOR); Abe, Yutaro¹ (AUTHOR)

Source: Current Oncology. Mar2024, Vol. 31 Issue 3, p1543-1555. 13p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Efficacy and Safety of Bevacizumab Biosimilar (Encoda) Compared With Reference Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer: A Multicenter, Real-World Study.

Authors : Shan, Han^1,2 (AUTHOR); Wang, Mengmeng^1,2 (AUTHOR); Huang, Shuohan^1,2,3 (AUTHOR)

Source: Clinical Medicine Insights: Oncology. 12/11/2024, p1-11. 11p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Organ‐specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.

Authors : Cheon, Jaekyung¹ (AUTHOR); Jung, Sanghoon² (AUTHOR); Kim, Jung Sun¹ (AUTHOR)

Source: Liver International. Aug2024, Vol. 44 Issue 8, p1961-1970. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Cost-effectiveness analysis of continuing bevacizumab plus chemotherapy versus chemotherapy alone after first progression of metastatic colorectal cancer.

Authors : Yulian Li¹; Min Hu¹; Zhe Zhang¹

Source: Cancer Medicine. Jan2024, Vol. 13 Issue 1, p1-10. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Administration of Bevacizumab and the Risk of Chronic Kidney Disease Development in Taiwan Residents: A Population-Based Retrospective Cohort Study.

Authors : Lye, Lon-Fye¹ (AUTHOR) ; Chou, Ruey-Hwang^2,3,4 (AUTHOR) ; Wu, Tsai-Kun^5,6 (AUTHOR)

Source: International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p340. 11p.

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma.

Intraperitoneal Chemotherapy without Bevacizumab versus Intravenous Chemotherapy with Bevacizumab as the Frontline Adjuvant Therapy in Advanced Ovarian Cancer.

Basic Fibroblast Growth Factor Accumulation in Culture Medium Masks the Direct Antitumor Effect of Anti-VEGF Agent Bevacizumab.

Progression pattern and post‐progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.

Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab.

Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma.

Efficacy and Safety of Bevacizumab Biosimilar (Encoda) Compared With Reference Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer: A Multicenter, Real-World Study.

Organ‐specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.

Cost-effectiveness analysis of continuing bevacizumab plus chemotherapy versus chemotherapy alone after first progression of metastatic colorectal cancer.

Administration of Bevacizumab and the Risk of Chronic Kidney Disease Development in Taiwan Residents: A Population-Based Retrospective Cohort Study.

Contact

Follow us